Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,11,0.87 [0.82-0.92],5.3854392605454e-06,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MEP1B,Meprin A subunit beta,Inverse variance weighted,11,0.9 [0.86-0.94],8.43389947899012e-06,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,11,1.1 [1.04-1.16],0.000263535004246295,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA6,Carbonic anhydrase 6,Inverse variance weighted,11,0.91 [0.87-0.96],0.000299733441015069,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,11,1.1 [1.04-1.17],0.000627685838390687,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNR,Tenascin-R,Inverse variance weighted,11,0.91 [0.86-0.96],0.000699232369941406,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDHR2,Cadherin-related family member 2,Inverse variance weighted,11,1.09 [1.04-1.14],0.000747570118344802,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,11,1.1 [1.04-1.16],0.00134070729007742,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGA11,Integrin alpha-11,Inverse variance weighted,11,0.91 [0.86-0.97],0.00149214050748288,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,11,0.91 [0.86-0.97],0.00186141683443839,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,11,1.11 [1.04-1.18],0.0019805355534637,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,0.92 [0.87-0.97],0.00198486827814046,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,11,1.09 [1.03-1.16],0.00200933064619557,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,0.92 [0.87-0.97],0.00270380252423396,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,11,1.1 [1.03-1.17],0.00307226618150627,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,11,0.92 [0.87-0.97],0.00310697160935272,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,11,1.09 [1.03-1.15],0.00323226225140722,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CPM,Carboxypeptidase M,Inverse variance weighted,11,1.11 [1.03-1.18],0.00323743479724101,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,11,1.1 [1.03-1.18],0.00338042446845449,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,11,1.07 [1.02-1.12],0.0035320784741428,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SELENOP,Selenoprotein P,Inverse variance weighted,11,0.89 [0.82-0.96],0.00421666146208947,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,0.92 [0.88-0.98],0.00428044144795534,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RBP5,Retinol-binding protein 5,Inverse variance weighted,11,1.09 [1.03-1.16],0.00429233759496291,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGAV,Integrin alpha-V,Inverse variance weighted,11,0.93 [0.88-0.98],0.00616624277268336,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PI3,Elafin,Inverse variance weighted,11,1.08 [1.02-1.14],0.00709667574722643,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,11,1.08 [1.02-1.15],0.00734193847491473,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,11,0.91 [0.85-0.98],0.00769620496895235,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,UMOD,Uromodulin,Inverse variance weighted,11,0.94 [0.89-0.98],0.00782470722059049,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL22,Interleukin-22,Inverse variance weighted,11,1.08 [1.02-1.15],0.00806170911667199,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,11,1.08 [1.02-1.14],0.00869773256536845,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC3B,Tetranectin,Inverse variance weighted,11,0.93 [0.88-0.98],0.00877425955529201,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,11,0.94 [0.89-0.98],0.0100958198361285,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,11,1.08 [1.02-1.14],0.0106547594554668,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,11,1.08 [1.02-1.14],0.0107106617597515,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ULBP2,UL16-binding protein 2,Inverse variance weighted,11,0.93 [0.89-0.99],0.0119261546600461,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KITLG,Kit ligand,Inverse variance weighted,11,0.93 [0.88-0.98],0.0121711666715013,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,11,0.94 [0.89-0.99],0.0124029655932199,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP12,Macrophage metalloelastase,Inverse variance weighted,11,1.07 [1.01-1.12],0.0124334323797025,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,11,1.07 [1.01-1.13],0.01436279661104,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,11,0.93 [0.88-0.99],0.0181534797830093,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,11,1.06 [1.01-1.12],0.0202674630177497,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.93 [0.88-0.99],0.0225053454587471,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,11,1.07 [1.01-1.14],0.0232297287577404,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REN,Renin,Inverse variance weighted,11,1.07 [1.01-1.14],0.0236954100337189,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,11,0.92 [0.85-0.99],0.0249705883247839,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KYNU,Kynureninase,Inverse variance weighted,11,1.07 [1.01-1.13],0.0250078033048373,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,11,0.93 [0.87-0.99],0.0251628716580267,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,11,1.07 [1.01-1.13],0.026881725774466,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM3C,Protein FAM3C,Inverse variance weighted,11,0.94 [0.89-0.99],0.0271031775833205,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,11,1.07 [1.01-1.13],0.027686041631854,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSLN,Mesothelin,Inverse variance weighted,11,1.06 [1.01-1.12],0.0280000951898588,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,11,1.05 [1-1.11],0.0314124311912801,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,11,1.07 [1-1.13],0.0345103693394842,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OMD,Osteomodulin,Inverse variance weighted,11,0.93 [0.86-0.99],0.035030201790703,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,11,0.95 [0.9-1],0.0372701433805597,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,11,1.09 [1.01-1.19],0.0378737860508016,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.07 [1-1.14],0.0383747873948804,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,11,0.94 [0.88-1],0.0393241044261031,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RGMA,Repulsive guidance molecule A,Inverse variance weighted,11,0.91 [0.84-1],0.0424576320227338,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,11,1.06 [1-1.12],0.0447342434108799,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,11,0.95 [0.9-1],0.0452512282549205,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HGF,Hepatocyte growth factor,Inverse variance weighted,11,1.07 [1-1.14],0.0457776678287662,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LY96,Lymphocyte antigen 96,Inverse variance weighted,11,1.06 [1-1.12],0.0470008687444885,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,11,1.08 [1-1.17],0.0470198220488857,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,11,1.06 [1-1.12],0.0502243952917572,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNTN5,Contactin-5,Inverse variance weighted,11,0.94 [0.87-1],0.0524997427991381,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPC5,Glypican-5,Inverse variance weighted,11,0.95 [0.91-1],0.0532340875647115,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAL,Galanin peptides,Inverse variance weighted,11,0.94 [0.89-1],0.0537322194594966,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GSN,Gelsolin,Inverse variance weighted,11,0.94 [0.87-1],0.0568749135446323,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,11,1.06 [1-1.12],0.0577923767931077,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,11,1.06 [1-1.12],0.059263669806615,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSD,Cathepsin D,Inverse variance weighted,11,1.05 [1-1.11],0.0592712649100681,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.05 [1-1.11],0.0621268572065692,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,11,1.06 [1-1.13],0.0646515646271846,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,11,1.08 [0.99-1.17],0.0709244341321066,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,11,1.06 [1-1.13],0.0712001502351227,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,11,0.95 [0.89-1],0.071592700397216,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,11,1.05 [1-1.11],0.071632278902969,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,11,0.94 [0.87-1.01],0.0720401390228788,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,11,0.96 [0.91-1],0.0756371915895557,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PVR,Poliovirus receptor,Inverse variance weighted,11,0.94 [0.87-1.01],0.0765449874433999,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,11,0.95 [0.9-1.01],0.0769638382951429,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CALCA,Calcitonin,Inverse variance weighted,11,1.04 [1-1.09],0.0772879859319569,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,APLP1,Amyloid-like protein 1,Inverse variance weighted,11,0.95 [0.9-1.01],0.0793258476098646,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TCTN3,Tectonic-3,Inverse variance weighted,11,1.05 [0.99-1.11],0.0794344170083747,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL15,Interleukin-15,Inverse variance weighted,11,1.05 [0.99-1.11],0.0823519306203599,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,11,1.05 [0.99-1.12],0.0847154621265995,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLSTN2,Calsyntenin-2,Inverse variance weighted,11,0.95 [0.9-1.01],0.0851590440578941,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,11,1.05 [0.99-1.12],0.0859805087078493,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MATN2,Matrilin-2,Inverse variance weighted,11,0.95 [0.9-1.01],0.0882461226431487,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDH2,Cadherin-2,Inverse variance weighted,11,1.06 [0.99-1.13],0.0911598014225866,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD248,Endosialin,Inverse variance weighted,11,0.94 [0.88-1.01],0.0932101714543268,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IDUA,Alpha-L-iduronidase,Inverse variance weighted,11,1.06 [0.99-1.13],0.0935555373911141,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SELE,E-selectin,Inverse variance weighted,11,1.04 [0.99-1.09],0.0945624774733752,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,11,1.06 [0.99-1.13],0.0978528011668611,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AMBP,Protein AMBP,Inverse variance weighted,11,1.05 [0.99-1.11],0.0986309207738783,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCLY,Selenocysteine lyase,Inverse variance weighted,11,1.05 [0.99-1.11],0.103696815032071,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,11,1.05 [0.99-1.12],0.104381043036174,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Inverse variance weighted,11,1.05 [0.99-1.11],0.104778848906464,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAST,Gastrin,Inverse variance weighted,11,1.05 [0.99-1.11],0.108501288638361,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,11,0.96 [0.92-1.01],0.111143736072497,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSZ,Cathepsin Z,Inverse variance weighted,11,1.05 [0.99-1.13],0.114947643762598,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS2,Trypsin-2,Inverse variance weighted,11,1.05 [0.99-1.11],0.116738992412253,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL21,C-C motif chemokine 21,Inverse variance weighted,11,1.06 [0.99-1.14],0.117837388032422,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK11,Kallikrein-11,Inverse variance weighted,11,0.96 [0.91-1.01],0.122205297728457,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,11,0.96 [0.91-1.01],0.125011398827541,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,11,1.04 [0.99-1.1],0.128154630997938,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,0.94 [0.87-1.02],0.129345534881349,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.05 [0.99-1.11],0.129550051233525,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,11,1.04 [0.99-1.09],0.129697334655593,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL27,C-C motif chemokine 27,Inverse variance weighted,11,1.04 [0.99-1.1],0.132671094521068,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,11,1.04 [0.99-1.1],0.134942624153263,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,11,1.04 [0.99-1.1],0.136172324148802,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,11,0.94 [0.87-1.02],0.136671456874624,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,11,0.96 [0.91-1.01],0.138627188552737,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,11,1.04 [0.99-1.09],0.14238030408859,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGA4,Pepsin A-4,Inverse variance weighted,11,0.95 [0.88-1.02],0.144652611332255,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,11,1.04 [0.99-1.11],0.144808980895366,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,11,1.05 [0.98-1.13],0.147168979745376,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PALM2,Paralemmin-2,Inverse variance weighted,11,1.05 [0.98-1.13],0.153086499736406,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,11,1.04 [0.99-1.09],0.154578498757843,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,11,0.95 [0.89-1.02],0.1563546697956,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANG,Angiogenin,Inverse variance weighted,11,1.05 [0.98-1.11],0.157529733329567,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE6,Ribonuclease K6,Inverse variance weighted,11,1.04 [0.98-1.1],0.162084505732401,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,0.96 [0.91-1.02],0.169856984725858,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,11,1.04 [0.98-1.09],0.171879885875381,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,11,1.05 [0.98-1.12],0.172692064867493,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,11,1.04 [0.98-1.1],0.173210331487447,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MET,Hepatocyte growth factor receptor,Inverse variance weighted,11,0.91 [0.79-1.04],0.173926620602936,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,11,1.05 [0.98-1.13],0.175101470873449,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OCLN,Occludin,Inverse variance weighted,11,1.04 [0.98-1.1],0.1764551391534,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,11,1.05 [0.98-1.14],0.177881458481591,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,11,0.96 [0.91-1.02],0.180328082161653,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLG,Plasminogen,Inverse variance weighted,11,1.04 [0.98-1.1],0.184105477135512,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,11,1.04 [0.98-1.11],0.186301021183402,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,11,1.05 [0.98-1.13],0.186649135057553,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DLL1,Delta-like protein 1,Inverse variance weighted,11,0.95 [0.87-1.03],0.191012930832994,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,11,1.04 [0.98-1.11],0.191130459357279,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGRN,Agrin,Inverse variance weighted,11,0.96 [0.91-1.02],0.193799816416806,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,1.04 [0.98-1.11],0.194792776696466,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,11,0.96 [0.91-1.02],0.195826059959229,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,11,1.05 [0.98-1.12],0.196686120587114,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NCAM1,Neural cell adhesion molecule 1,Inverse variance weighted,11,0.96 [0.9-1.02],0.196895372344391,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,11,0.95 [0.89-1.03],0.200574155880252,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,11,1.05 [0.97-1.14],0.200859590508122,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,11,0.96 [0.9-1.02],0.201840645152423,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,1.05 [0.97-1.13],0.20447045537722,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA11,Serpin A11,Inverse variance weighted,11,1.03 [0.98-1.08],0.207131680984242,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,11,1.03 [0.98-1.08],0.209138938338353,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CES1,Liver carboxylesterase 1,Inverse variance weighted,11,1.05 [0.97-1.14],0.209948299116118,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,11,1.07 [0.96-1.18],0.211727145595329,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CFB,Complement factor B,Inverse variance weighted,11,1.03 [0.98-1.09],0.213535967420575,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NT5E,5'-nucleotidase,Inverse variance weighted,11,1.04 [0.98-1.09],0.221353381964235,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,11,1.06 [0.97-1.16],0.222498606590603,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GOLM2,Protein GOLM2,Inverse variance weighted,11,1.05 [0.97-1.13],0.223855858681296,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,11,1.04 [0.98-1.11],0.225271609190225,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANXA10,Annexin A10,Inverse variance weighted,11,1.04 [0.98-1.1],0.225400898687654,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,0.96 [0.9-1.02],0.226727196437714,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNC,Tenascin,Inverse variance weighted,11,0.96 [0.9-1.03],0.229434770458236,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INSL3,Insulin-like 3,Inverse variance weighted,11,1.02 [0.99-1.06],0.234353234665792,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL22,C-C motif chemokine 22,Inverse variance weighted,11,1.04 [0.97-1.11],0.235473765659487,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,11,1.03 [0.98-1.09],0.23691735999235,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,11,1.04 [0.98-1.1],0.240895584156309,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,11,0.97 [0.91-1.02],0.245180666172575,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,11,0.97 [0.91-1.02],0.245299163527786,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,11,1.03 [0.98-1.07],0.250613381055341,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.04 [0.98-1.1],0.2513533523062,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,THBS2,Thrombospondin-2,Inverse variance weighted,11,1.03 [0.98-1.1],0.251952308097946,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FUOM,Fucose mutarotase,Inverse variance weighted,11,1.04 [0.97-1.11],0.253298039867564,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNTN1,Contactin-1,Inverse variance weighted,11,0.96 [0.9-1.03],0.257534719485326,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,11,0.97 [0.92-1.02],0.25839117643596,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,11,1.03 [0.98-1.09],0.259927614007536,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,11,0.95 [0.88-1.04],0.261119513060891,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,11,0.97 [0.92-1.02],0.265946388019641,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BCAN,Brevican core protein,Inverse variance weighted,11,0.97 [0.91-1.03],0.266487770199906,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP10,Stromelysin-2,Inverse variance weighted,11,0.97 [0.92-1.02],0.267908030308331,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BSG,Basigin,Inverse variance weighted,11,0.96 [0.9-1.03],0.267970864121166,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,11,1.05 [0.97-1.14],0.270612522476579,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,11,1.04 [0.97-1.1],0.271908613573602,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CREG1,Protein CREG1,Inverse variance weighted,11,1.05 [0.96-1.14],0.27198044097601,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,F9,Coagulation factor IX,Inverse variance weighted,11,1.05 [0.96-1.14],0.272037986958639,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CSTB,Cystatin-B,Inverse variance weighted,11,1.03 [0.98-1.08],0.275192250007095,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,11,0.97 [0.91-1.03],0.275655786742455,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,11,1.04 [0.97-1.11],0.276577147351591,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCRLB,Fc receptor-like B,Inverse variance weighted,11,1.03 [0.98-1.08],0.276620015756142,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,11,1.03 [0.97-1.09],0.276805095800464,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD48,CD48 antigen,Inverse variance weighted,11,0.97 [0.91-1.03],0.27705231382293,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,11,0.96 [0.89-1.04],0.280132087796,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,11,1.03 [0.98-1.09],0.281385697309429,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,11,1.03 [0.98-1.07],0.282127435537604,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPY30,Protein dpy-30 homolog,Inverse variance weighted,11,1.03 [0.97-1.09],0.282398249841159,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,11,1.03 [0.98-1.09],0.282826795248593,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,11,1.03 [0.97-1.09],0.286797171319624,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,11,1.03 [0.98-1.08],0.28715440435486,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADM,Pro-adrenomedullin,Inverse variance weighted,11,1.03 [0.97-1.1],0.287866812647467,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MME,Neprilysin,Inverse variance weighted,11,1.05 [0.96-1.14],0.29161852455667,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CFI,Complement factor I,Inverse variance weighted,11,1.03 [0.97-1.1],0.291691028821245,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,11,1.03 [0.98-1.08],0.293877359516586,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,11,1.03 [0.97-1.09],0.295043963466625,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,11,0.97 [0.91-1.03],0.296028556277102,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,11,1.04 [0.97-1.11],0.301368662294327,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP8,Neutrophil collagenase,Inverse variance weighted,11,1.03 [0.97-1.1],0.303274077965334,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,11,1.03 [0.97-1.1],0.30373058855212,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GLB1,Beta-galactosidase,Inverse variance weighted,11,1.03 [0.97-1.09],0.308358474496049,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,11,1.03 [0.97-1.1],0.31012995832408,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK4,Kallikrein-4,Inverse variance weighted,11,0.98 [0.93-1.02],0.312222687327357,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,11,1.03 [0.97-1.09],0.313026152820424,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.03 [0.98-1.08],0.314344075881468,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,11,0.97 [0.92-1.03],0.314769010146664,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PTN,Pleiotrophin,Inverse variance weighted,11,1.04 [0.97-1.11],0.314854039266823,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,11,1.03 [0.97-1.11],0.316527529218806,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,11,0.97 [0.91-1.03],0.317244111763755,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL11,Eotaxin,Inverse variance weighted,11,0.97 [0.91-1.03],0.319304266964605,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,11,0.97 [0.91-1.03],0.321556310637527,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,11,0.97 [0.92-1.03],0.324421475607352,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINB8,Serpin B8,Inverse variance weighted,11,1.02 [0.98-1.08],0.326386192852619,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COLEC12,Collectin-12,Inverse variance weighted,11,0.97 [0.91-1.03],0.329137766983521,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL28,C-C motif chemokine 28,Inverse variance weighted,11,0.97 [0.92-1.03],0.334679934608732,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLMP,CXADR-like membrane protein,Inverse variance weighted,11,0.97 [0.91-1.03],0.338427083552358,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,11,0.96 [0.89-1.04],0.348538117466961,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,11,1.03 [0.97-1.09],0.349938278944137,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GUSB,Beta-glucuronidase,Inverse variance weighted,11,1.03 [0.97-1.08],0.359552503101796,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,11,1.02 [0.97-1.08],0.359736465685115,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,11,1.02 [0.98-1.07],0.359865973510489,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLAMF7,SLAM family member 7,Inverse variance weighted,11,0.98 [0.93-1.03],0.360925776864073,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF2,Trefoil factor 2,Inverse variance weighted,11,1.03 [0.97-1.09],0.361156474610669,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP7,Matrilysin,Inverse variance weighted,11,1.03 [0.97-1.09],0.364114174039527,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,11,1.03 [0.97-1.08],0.370439667419787,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,11,0.96 [0.89-1.04],0.373343173756626,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,11,1.03 [0.96-1.11],0.373536540703169,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK10,Kallikrein-10,Inverse variance weighted,11,1.02 [0.97-1.08],0.374548376525738,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,11,1.03 [0.96-1.1],0.374827546881422,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSM,Oncostatin-M,Inverse variance weighted,11,1.03 [0.97-1.09],0.375339573885333,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,11,0.98 [0.92-1.03],0.38038580987378,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.97 [0.9-1.04],0.382363284539678,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,11,0.98 [0.92-1.03],0.384353797310108,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,11,1.04 [0.95-1.14],0.39119472242056,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,11,0.97 [0.9-1.04],0.3920439247317,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,11,1.03 [0.97-1.09],0.392697660076625,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.98 [0.92-1.03],0.393570926763713,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SHISA5,Protein shisa-5,Inverse variance weighted,11,1.06 [0.93-1.2],0.393683594337577,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,11,1.03 [0.96-1.11],0.395475258285496,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,11,1.03 [0.96-1.1],0.396792776895218,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,11,1.02 [0.97-1.08],0.399970647683751,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CAPG,Macrophage-capping protein,Inverse variance weighted,11,1.02 [0.97-1.08],0.40022218018902,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,11,1.03 [0.96-1.1],0.404180836079507,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,11,1.02 [0.97-1.08],0.406365781794612,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MDK,Midkine,Inverse variance weighted,11,1.02 [0.97-1.08],0.406571922269947,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL20,C-C motif chemokine 20,Inverse variance weighted,11,0.98 [0.92-1.03],0.40730722690299,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DTNB,Dystrobrevin beta,Inverse variance weighted,11,1.02 [0.97-1.08],0.409998460991492,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,11,0.97 [0.89-1.05],0.415040599746535,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF1,Trefoil factor 1,Inverse variance weighted,11,1.02 [0.97-1.09],0.418432729828481,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,11,0.98 [0.92-1.03],0.422942321715388,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,11,1.02 [0.97-1.08],0.426500253152628,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,11,1.02 [0.97-1.07],0.431715797404353,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASET2,Ribonuclease T2,Inverse variance weighted,11,1.03 [0.96-1.1],0.433611628786576,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,11,1.03 [0.96-1.09],0.437183480442083,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FURIN,Furin,Inverse variance weighted,11,1.03 [0.95-1.11],0.443510129214956,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,11,0.98 [0.93-1.03],0.445605268957052,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SEPTIN8,Septin-8,Inverse variance weighted,11,1.03 [0.95-1.12],0.44761210634962,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,11,1.03 [0.95-1.12],0.448638438294411,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,11,1.03 [0.95-1.11],0.452849125549374,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VWC2,Brorin,Inverse variance weighted,11,0.98 [0.92-1.04],0.455487223660461,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,11,1.02 [0.97-1.08],0.4571560175469,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,11,1.02 [0.97-1.07],0.45722043956319,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,11,0.98 [0.92-1.04],0.459441455497268,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,11,0.98 [0.92-1.04],0.466655684976471,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSMB,Beta-microseminoprotein,Inverse variance weighted,11,1.02 [0.97-1.07],0.470273957833876,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,11,0.98 [0.92-1.04],0.471475384748884,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,11,1.02 [0.96-1.09],0.472447786274695,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,11,0.97 [0.88-1.06],0.474658541155523,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGMN,Legumain,Inverse variance weighted,11,1.03 [0.96-1.1],0.480350442350972,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,0.98 [0.93-1.04],0.48118454781028,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,11,1.02 [0.96-1.08],0.481719565915474,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RSPO1,R-spondin-1,Inverse variance weighted,11,1.03 [0.94-1.14],0.482165816387612,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,APCS,Serum amyloid P-component,Inverse variance weighted,11,1.02 [0.97-1.08],0.48316224110923,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM3B,Protein FAM3B,Inverse variance weighted,11,0.98 [0.93-1.03],0.485129061980516,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLAMF8,SLAM family member 8,Inverse variance weighted,11,1.02 [0.96-1.09],0.486303018036675,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,11,0.98 [0.93-1.04],0.491667029389255,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,11,1.02 [0.96-1.09],0.49269040197873,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,11,1.02 [0.96-1.1],0.493953161710872,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,11,1.02 [0.97-1.07],0.494124799175279,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EZR,Ezrin,Inverse variance weighted,11,0.98 [0.93-1.04],0.495358239739115,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL19,Interleukin-19,Inverse variance weighted,11,1.02 [0.96-1.08],0.496202015567468,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPD1,Glycerol-3-phosphate dehydrogenase,Inverse variance weighted,11,1.02 [0.96-1.08],0.497823705240881,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,11,0.96 [0.86-1.08],0.500572360114379,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,11,1.02 [0.96-1.09],0.500643586418679,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MFGE8,Lactadherin,Inverse variance weighted,11,0.97 [0.9-1.06],0.50102291235682,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,11,0.98 [0.91-1.05],0.501550543222168,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,11,1.03 [0.95-1.11],0.501624619070414,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,11,1.02 [0.96-1.09],0.501705975738696,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,11,1.02 [0.96-1.08],0.510769174733955,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,11,0.98 [0.93-1.04],0.511809940566323,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,11,0.98 [0.93-1.04],0.511827816365049,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.02 [0.96-1.08],0.512885731841138,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,11,1.02 [0.96-1.08],0.514551351637432,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,11,0.98 [0.9-1.05],0.515996668318239,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HEG1,Protein HEG homolog 1,Inverse variance weighted,11,1.03 [0.95-1.11],0.516383595748549,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,11,1.02 [0.96-1.09],0.51772399583186,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHGA,Chromogranin-A,Inverse variance weighted,11,0.98 [0.92-1.04],0.51781946036017,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.02 [0.97-1.07],0.518179229737773,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.02 [0.96-1.09],0.519194825058409,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,11,0.98 [0.93-1.04],0.51954101078038,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,11,1.02 [0.96-1.08],0.521071807626882,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,11,0.98 [0.93-1.04],0.521815315742996,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,11,1.02 [0.97-1.07],0.522193337170131,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,11,1.02 [0.95-1.1],0.523992578071734,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PSAP,Prosaposin,Inverse variance weighted,11,1.02 [0.95-1.11],0.529695757046221,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,11,1.02 [0.96-1.08],0.531373014275867,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS3,Galectin-3,Inverse variance weighted,11,0.98 [0.94-1.03],0.533227087076867,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,11,1.02 [0.95-1.1],0.533893154008743,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,11,0.98 [0.9-1.06],0.536240973169744,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL17,C-C motif chemokine 17,Inverse variance weighted,11,0.98 [0.93-1.04],0.539050458168404,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,11,0.98 [0.93-1.04],0.545034427448686,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,11,0.98 [0.93-1.04],0.54620830379783,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPPB,Natriuretic peptides B,Inverse variance weighted,11,0.98 [0.93-1.04],0.549880418047909,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,11,0.98 [0.91-1.05],0.549945793659305,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL32,Interleukin-32,Inverse variance weighted,11,1.02 [0.95-1.09],0.549947092716271,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,11,0.99 [0.94-1.04],0.559740445805734,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACY1,Aminoacylase-1,Inverse variance weighted,11,1.02 [0.96-1.09],0.560855046795976,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,11,1.02 [0.96-1.07],0.562825817689995,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADA2,Adenosine deaminase 2,Inverse variance weighted,11,1.02 [0.96-1.08],0.56362951349594,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,11,0.98 [0.93-1.04],0.564964475667849,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,11,1.02 [0.96-1.08],0.565994413020888,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,11,1.02 [0.96-1.07],0.569969062773554,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAYN,Layilin,Inverse variance weighted,11,0.98 [0.93-1.04],0.571414063061502,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL23,C-C motif chemokine 23,Inverse variance weighted,11,0.98 [0.93-1.04],0.572222252261663,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,11,0.98 [0.9-1.06],0.572329311502828,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIAE,Sialate O-acetylesterase,Inverse variance weighted,11,0.98 [0.93-1.04],0.572997575636344,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.02 [0.95-1.1],0.573335782775347,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,11,0.98 [0.92-1.05],0.576516360821674,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B2M,Beta-2-microglobulin,Inverse variance weighted,11,1.02 [0.95-1.09],0.58260991485502,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.02 [0.96-1.08],0.588209105086266,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFNA4,Ephrin-A4,Inverse variance weighted,11,0.98 [0.93-1.04],0.589279453980914,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,11,1.02 [0.96-1.07],0.589318059901476,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS4,Galectin-4,Inverse variance weighted,11,1.02 [0.96-1.07],0.589860014172903,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,11,1.02 [0.96-1.07],0.590123783651438,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTA4H,Leukotriene A-4 hydrolase,Inverse variance weighted,11,1.02 [0.95-1.09],0.591752690984502,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,11,1.02 [0.96-1.08],0.59352700452197,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,11,1.02 [0.94-1.1],0.597723568796768,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,11,1.01 [0.96-1.07],0.598128584820586,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TCN2,Transcobalamin-2,Inverse variance weighted,11,1.01 [0.96-1.07],0.599935005330456,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,11,1.01 [0.96-1.07],0.600464930086056,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,11,0.98 [0.93-1.04],0.606462188098871,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,11,0.99 [0.94-1.04],0.608402207879456,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,11,0.99 [0.95-1.03],0.611594279823961,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD59,CD59 glycoprotein,Inverse variance weighted,11,0.99 [0.93-1.04],0.611695767510988,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CST3,Cystatin-C,Inverse variance weighted,11,1.01 [0.96-1.07],0.612569094420376,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,11,0.98 [0.91-1.06],0.617214125459608,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,11,0.98 [0.91-1.06],0.62331889687707,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,11,0.99 [0.93-1.04],0.626375863124708,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,11,1.01 [0.96-1.07],0.626972627861522,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,11,0.98 [0.92-1.06],0.630305130023173,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGF,Placenta growth factor,Inverse variance weighted,11,1.01 [0.96-1.07],0.630747454789046,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,11,0.98 [0.92-1.05],0.631198811526316,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,11,0.99 [0.95-1.03],0.632127162751729,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSL,Cathepsin L1,Inverse variance weighted,11,1.01 [0.96-1.07],0.634518072128199,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN4,CCN family member 4,Inverse variance weighted,11,1.01 [0.96-1.07],0.638716398003085,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,11,1.01 [0.96-1.07],0.639554656669904,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,STC1,Stanniocalcin-1,Inverse variance weighted,11,0.98 [0.92-1.05],0.640528346144127,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,11,1.02 [0.95-1.09],0.645521211040116,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.01 [0.96-1.07],0.647335082488113,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN1,CCN family member 1,Inverse variance weighted,11,0.98 [0.92-1.05],0.647864745020014,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HMOX2,Heme oxygenase 2,Inverse variance weighted,11,1.01 [0.96-1.07],0.649413045029008,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,11,1.02 [0.95-1.09],0.650483381502282,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MVK,Mevalonate kinase,Inverse variance weighted,11,1.01 [0.96-1.07],0.650672501127527,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G1B,Phospholipase A2,Inverse variance weighted,11,0.99 [0.93-1.05],0.650953241871059,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,11,1.01 [0.96-1.06],0.656664862398134,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NECTIN2,Nectin-2,Inverse variance weighted,11,1.01 [0.96-1.07],0.657565773511664,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,11,0.99 [0.94-1.04],0.658326382051929,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,11,0.99 [0.93-1.04],0.662476706692143,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPON1,Spondin-1,Inverse variance weighted,11,1.02 [0.95-1.09],0.666753725894996,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AREG,Amphiregulin,Inverse variance weighted,11,1.01 [0.95-1.08],0.66837179615191,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,11,1.01 [0.96-1.07],0.67243495476435,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,11,1.01 [0.96-1.07],0.672844905922181,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LMNB2,Lamin-B2,Inverse variance weighted,11,1.02 [0.94-1.1],0.675129555083518,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,11,1.01 [0.96-1.07],0.677840406122961,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,11,0.98 [0.91-1.06],0.679146940725928,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.99 [0.93-1.05],0.680015638722883,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,11,0.99 [0.94-1.04],0.682562655594311,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF9,Protein turtle homolog A,Inverse variance weighted,11,1.02 [0.94-1.09],0.684961511266914,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,11,1.01 [0.94-1.09],0.695230059513668,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSF,Cathepsin F,Inverse variance weighted,11,0.98 [0.91-1.06],0.695357986040116,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,11,0.99 [0.93-1.05],0.695683631830332,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL25,C-C motif chemokine 25,Inverse variance weighted,11,0.99 [0.94-1.04],0.695719250733994,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL17C,Interleukin-17C,Inverse variance weighted,11,0.99 [0.93-1.05],0.696004707198723,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,11,1.01 [0.96-1.07],0.696548178716469,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,11,1.01 [0.95-1.07],0.699645465687566,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF3,Trefoil factor 3,Inverse variance weighted,11,1.01 [0.94-1.09],0.701784915857219,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,11,0.99 [0.93-1.05],0.703310034565479,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGLN1,Egl nine homolog 1,Inverse variance weighted,11,1.01 [0.95-1.08],0.706277429861109,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA4,Carbonic anhydrase 4,Inverse variance weighted,11,1.01 [0.95-1.08],0.710664424769637,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RSPO3,R-spondin-3,Inverse variance weighted,11,1.02 [0.93-1.11],0.711435599802313,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,11,1.01 [0.94-1.1],0.715134058536095,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL5,C-C motif chemokine 5,Inverse variance weighted,11,1.01 [0.95-1.07],0.718700791223635,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,11,1.01 [0.95-1.08],0.724698019971226,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,11,1.01 [0.96-1.06],0.724979994777272,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,11,0.99 [0.94-1.05],0.732375719516925,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD27,CD27 antigen,Inverse variance weighted,11,1.01 [0.95-1.07],0.735730696566391,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,11,1.01 [0.95-1.08],0.736007834798281,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDN1,Endothelin-1,Inverse variance weighted,11,1.01 [0.95-1.08],0.736628221560332,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP1,Insulin-like growth factor-binding protein 1,Inverse variance weighted,11,1.01 [0.95-1.07],0.736668431363775,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,11,1.01 [0.94-1.09],0.742558710821757,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,11,1.01 [0.95-1.07],0.744274073281943,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,11,0.99 [0.92-1.06],0.744399337665401,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,11,1.01 [0.94-1.09],0.749133807761487,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,11,1.01 [0.95-1.08],0.751028138394621,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,11,0.99 [0.91-1.07],0.754802502384408,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PYY,Peptide YY,Inverse variance weighted,11,0.99 [0.92-1.06],0.755770961374323,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,11,1.01 [0.93-1.1],0.757251178775917,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,11,1.01 [0.95-1.08],0.765734146737136,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,11,1.01 [0.96-1.06],0.766678497242761,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,11,1.01 [0.96-1.06],0.778811413183195,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN3,CCN family member 3,Inverse variance weighted,11,1.01 [0.95-1.07],0.781809494263607,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,11,1.01 [0.95-1.07],0.78215606237769,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.01 [0.95-1.07],0.783290834424992,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,11,1.01 [0.95-1.07],0.783527210051308,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,11,0.99 [0.94-1.05],0.783714480566597,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPIND1,Heparin cofactor 2,Inverse variance weighted,11,1.01 [0.95-1.07],0.784206086997499,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,11,1.01 [0.95-1.07],0.790243112748608,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL16,C-C motif chemokine 16,Inverse variance weighted,11,0.99 [0.93-1.05],0.797674676063416,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NFASC,Neurofascin,Inverse variance weighted,11,0.99 [0.94-1.05],0.798928756624255,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,11,0.99 [0.93-1.06],0.801429180066189,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.99 [0.92-1.07],0.802565942031664,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,11,0.99 [0.94-1.05],0.803020811325228,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,11,1.01 [0.95-1.07],0.803920868842962,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,11,1.01 [0.93-1.1],0.803992590886985,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS9,Galectin-9,Inverse variance weighted,11,1.01 [0.95-1.06],0.807212305374752,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPA1,Pulmonary surfactant-associated protein A1,Inverse variance weighted,11,0.99 [0.94-1.05],0.808587834715766,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,11,0.99 [0.94-1.05],0.813712444852197,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,0.99 [0.94-1.05],0.81512445382327,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,11,0.99 [0.94-1.05],0.817202631965029,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL3,C-C motif chemokine 3,Inverse variance weighted,11,1.01 [0.95-1.06],0.818468583678592,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,11,0.99 [0.94-1.05],0.821186474027778,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.01 [0.96-1.06],0.823570480566558,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS1,Galectin-1,Inverse variance weighted,11,1.01 [0.95-1.07],0.823947968753461,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CBLN4,Cerebellin-4,Inverse variance weighted,11,1.01 [0.94-1.08],0.824149042251804,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,11,0.99 [0.93-1.06],0.82490658616145,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FST,Follistatin,Inverse variance weighted,11,0.99 [0.93-1.06],0.830517166043051,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPON2,Spondin-2,Inverse variance weighted,11,1.01 [0.95-1.07],0.839223269192657,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,11,0.99 [0.95-1.05],0.844370195300088,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGA5,Integrin alpha-5,Inverse variance weighted,11,1.01 [0.93-1.09],0.844557687016419,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,11,0.99 [0.94-1.06],0.845443309062241,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,11,0.99 [0.94-1.05],0.850911909607002,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GLA,Alpha-galactosidase A,Inverse variance weighted,11,1.01 [0.92-1.1],0.851009004598113,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.99 [0.93-1.06],0.856199953614396,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,11,1.01 [0.95-1.07],0.860803418572311,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS8,Prostasin,Inverse variance weighted,11,0.99 [0.93-1.06],0.863709902010569,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLGN,Calmegin,Inverse variance weighted,11,1 [0.94-1.05],0.866016097948587,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,11,1 [0.94-1.05],0.866511130057674,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,11,1.01 [0.94-1.08],0.869036080863541,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,11,1 [0.94-1.05],0.877318735230159,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,11,1 [0.95-1.06],0.877700427561426,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TTR,Transthyretin,Inverse variance weighted,11,1 [0.94-1.05],0.885320289347848,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,11,1 [0.94-1.06],0.889703485904955,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFER,FAD-linked sulfhydryl oxidase ALR,Inverse variance weighted,11,1 [0.94-1.05],0.890157898628205,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1 [0.95-1.06],0.890405377154189,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,11,1 [0.94-1.05],0.891299904637844,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC1,Sialoadhesin,Inverse variance weighted,11,1 [0.94-1.06],0.892703510309378,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD302,CD302 antigen,Inverse variance weighted,11,1 [0.94-1.05],0.89626053756274,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL7,C-C motif chemokine 7,Inverse variance weighted,11,1 [0.94-1.08],0.896439007408987,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,11,1 [0.92-1.07],0.89770469196384,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB1A1,Uteroglobin,Inverse variance weighted,11,1 [0.94-1.05],0.900234476591366,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,1 [0.94-1.05],0.901526979576689,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP5,Fatty acid-binding protein 5,Inverse variance weighted,11,1 [0.95-1.06],0.904481207450177,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CST7,Cystatin-F,Inverse variance weighted,11,1 [0.96-1.05],0.905070518788218,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18,Interleukin-18,Inverse variance weighted,11,1 [0.95-1.06],0.908201913132347,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NCAN,Neurocan core protein,Inverse variance weighted,11,1 [0.93-1.07],0.909993236452757,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,11,1 [0.93-1.07],0.910453300418308,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,11,1 [0.95-1.06],0.912723177223334,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,11,1 [0.95-1.06],0.916254546527346,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,11,1 [0.92-1.08],0.920275776240799,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,11,1 [0.95-1.05],0.922494628383353,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL15,C-C motif chemokine 15,Inverse variance weighted,11,1 [0.96-1.05],0.925456942447251,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG1B,Lithostathine-1-beta,Inverse variance weighted,11,1 [0.94-1.06],0.927596591274794,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,11,1 [0.95-1.05],0.927648008639428,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCN1,Ficolin-1,Inverse variance weighted,11,1 [0.94-1.06],0.929028242719818,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,11,1 [0.93-1.08],0.929695629945147,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD276,CD276 antigen,Inverse variance weighted,11,1 [0.94-1.06],0.931502533604584,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,11,1 [0.95-1.05],0.933339703956509,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,11,1 [0.94-1.07],0.933739770777192,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GLO1,Lactoylglutathione lyase,Inverse variance weighted,11,1 [0.95-1.06],0.936762421205865,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,11,1 [0.95-1.06],0.938161538812796,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RBP2,Retinol-binding protein 2,Inverse variance weighted,11,1 [0.92-1.09],0.938250700419179,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,11,1 [0.94-1.06],0.938744158643718,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,11,1 [0.95-1.06],0.940321557599323,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,11,1 [0.93-1.08],0.941522403439591,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,THOP1,Thimet oligopeptidase,Inverse variance weighted,11,1 [0.94-1.05],0.941933284096872,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,11,1 [0.94-1.06],0.945558256900258,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,11,1 [0.94-1.07],0.948613188845598,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,11,1 [0.95-1.05],0.949896603644297,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,11,1 [0.95-1.06],0.949906637059502,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,11,1 [0.93-1.08],0.951473640515578,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,11,1 [0.93-1.07],0.954864718830637,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,11,1 [0.94-1.06],0.955670148705161,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ELN,Elastin,Inverse variance weighted,11,1 [0.95-1.05],0.960479018240649,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,11,1 [0.94-1.07],0.96211685223995,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,11,1 [0.95-1.06],0.96331426545394,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GRN,Progranulin,Inverse variance weighted,11,1 [0.93-1.07],0.965695105602916,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HYAL1,Hyaluronidase-1,Inverse variance weighted,11,1 [0.9-1.1],0.966966576905488,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,11,1 [0.93-1.07],0.971883721980126,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,11,1 [0.94-1.07],0.971915331850554,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,C7,Complement component C7,Inverse variance weighted,11,1 [0.95-1.05],0.972472672456407,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,11,1 [0.94-1.06],0.977648632421253,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,11,1 [0.94-1.07],0.979913013757201,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,11,1 [0.95-1.06],0.988591274115961,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,11,1 [0.94-1.07],0.99351929216961,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD83,CD83 antigen,Inverse variance weighted,11,1 [0.92-1.08],0.998101970962158,trans
